Nevro Corp Announces Issuance of Additional Key U.S. Patents for Innovative Chronic Pain Treatment  
1/24/2013 9:50:36 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Nevro Corp., a medical device company focused on improving the lives of patients suffering from debilitating chronic pain, announced today the issuance of four additional key patents related to the company’s Senza® system and HF10™ SCS therapy.